期刊文献+

心肌特异性启动子表达载体的构建及其功能鉴定

Construction and characterization of cardiac specific promoter-driven expression vector
原文传递
导出
摘要 本研究构建了心肌特异性α-肌球蛋白重链(α-MHC)启动子表达载体,并对其功能进行了鉴定。以小鼠基因组DNA为模板,通过PCR扩增得到α-MHC启动子,插入pGEM-TEasy载体,酶切后回收目的片段,置换pcDNA3.1(+)-EGFP-hygro中的CMV启动子,成功构建出α-MHC-EGFP表达载体。对其进行酶切鉴定后,通过电穿孔法转染原代小鼠心肌细胞,转染阳性的心肌细胞出现绿色荧光,而非心肌细胞无荧光出现。α-MHC-EGFP表达载体具有心肌特异性表达特性,可用于纯化胚胎干细胞来源的心肌细胞。 We constructed and identified cardiac-specific α-myosin heavy chain (α-MHC) promoter-driven expression vector. α-MHC promoter was amplified by PCR by using mouse genomic DNA as template and inserted into pGEM-T Easy vector. The inserted fragment was released by enzyme digestion, and then the cytomegalo virus (CMV) promoter in pcDNA3.1 (+)-EGFP-hygro vector was replaced by the α-MHC promoter to construct α-MHC-EGFP expression vector. After identification with enzyme digestion, α-MHC-EGFP was transfected into mouse primary cardiomyocytes by electroporation. Green fluorescence could be observed in transfected cardiomyocytes, but not in transfected non-cadiomyocytes, α-MHC-EGFP expression vector was specifically expressed in cardiomyocytes, and could be used to purify embryonic stem cell-derived cardiomyocytes.
出处 《生物工程学报》 CAS CSCD 北大核心 2009年第10期1546-1551,共6页 Chinese Journal of Biotechnology
基金 军队十一五计划课题青年学者项目(No.06Q86)资助~~
关键词 心肌细胞 胚胎干细胞 α-肌球蛋白重链 启动子 增强型绿色荧光蛋白 cardiomyoctyes embryonic stem cells α-myosin heavy chain promoter enhanced green fluorescent protein
  • 相关文献

参考文献11

  • 1Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol, 2005, 23(7): 845-856.
  • 2Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest, 2005, 115(3): 572-583.
  • 3Ye L, Haider HKh, Sim EK. Adult stem cells for cardiac repair: a choice between skeletal myoblasts and bone marrow stem ceils. Exp Biol Med (Maywood), 2006, 231(1): 8-19.
  • 4Menasche P. Skeletal myoblasts and cardiac repair. J Mol Cell Cardiol, 2008, 45(4): 545-553.
  • 5Hristov M, Weber C. The therapeutic potential of progenitor cells in ischemic heart disease-past, present and future. Basic Res Cardiol, 2006, 101(1): 1-7.
  • 6何文俊,陈昭烈.心肌组织工程研究进展[J].生物技术通讯,2009,20(3):426-429. 被引量:2
  • 7Klug MG, Soonpaa MH, Koh GY, et al. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest, 1996, 98(1): 216-224.
  • 8Saba Z, Nassar R, Ungerleider RM, et al. Cardiac troponin T isoform expression correlates with pathophysiological descriptors in patients who underwent corrective surgery for congenital heart disease. Circulation, 1996, 94(3): 472-476.
  • 9Liew CC, Jandreski MA. Construction and characterization of the alpha form of a cardiac myosin heavy chain cDNA clone and its developmental expression in the Syrian hamster. Proc Natl Acad Sci USA, 1986, 83(10): 3175-3179.
  • 10Gulick J, Subramaniam A, Neumann J, et al. Isolation and characterization of the mouse cardiac myosin heavy chain genes. JBiol Chem, 1991, 266(14): 9180-9185.

二级参考文献40

  • 1Zandonella C. Tissue engineering: The beat goes on[J]. Nature, 2003,421(6926):884-886.
  • 2Leor J, Amsalem Y, Cohen S. Ceils, scaffolds, and molecules for myocardial tissue engineering[J]. Pharmacol Ther, 2005,105(2):151- 163.
  • 3Minatoguchi S, Takemura G, Chen X H, et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment[J]. Circulation, 2004,109(21):2572-2580.
  • 4Laflamme M A, Murry C E. Regenerating the heart [J]. Nat Biotechnol, 2005,23(7):$45-856.
  • 5Li R K, Jia Z Q, Weisel R D, et al. Survival and function of bioengineered cardiac grafts[J]. Circulation, 1999,100(19 Suppl):II63- 69.
  • 6Leor J, Aboulafia-Etzion S, Dar A, et al. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium[J]. Circulation, 2000,102(19 Suppl 3):III56-61.
  • 7Kellar R S, Landeen L K, Shepherd B R, et al. Scaffold-based three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue[J]. Circulation, 2001,104(17):2063-2068.
  • 8Matsubayashi K, Fedak P W, Mickle D A, et al. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts[J]. Circulation, 2003,108(Suppl 1):II219-225.
  • 9Siepe M, Giraud M N, Pavlovic M, et al. Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure[J]. J Thorac Cardiovasc Surg, 2006,132(1):124- 131.
  • 10Ryu J H, Kim I K, Cho S W, et al. Implantation of bone marrow mononuclear ceils using injectable fibrin matrix enhances neovascularization in infarcted myoeardium[J]. Biomaterials, 2005,26(3):319- 326.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部